ClinicalTrials.Veeva

Menu

Cognitive and Mood Effects of Docosahexaenoic Acid (DHA)-Rich and Eicosapentaenoic Acid (EPA)-Rich Fish Oil in Healthy Young Adults

Northumbria University logo

Northumbria University

Status

Completed

Conditions

Cognitive Function
Mood

Treatments

Dietary Supplement: Placebo
Dietary Supplement: n-3 PUFAs

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

To date, only a small handful of studies have assessed the effects of omega-3 polyunsaturated fatty acids (n-3 PUFAs) on cognitive function in healthy adults. The results from these studies are mixed, and have differed greatly in terms of methodology as regards sample size, treatment formulation and duration of the intervention. In order to address these issues, the present study aims to assess the effects of two different formulations of fish oil in parallel, and at doses consistent with the current recommended daily intake of oily fish, across a range of cognitive domains. The aim of the present investigation is therefore to specifically evaluate the effects of 12 weeks supplementation of DHA-rich fish oil and EPA-rich fish oil dietary supplements on cognitive function in healthy young adults maintaining a regular diet containing oily fish not more than once a week. Self-report mood assessments will form the secondary part of this investigation.

Enrollment

159 patients

Sex

All

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male/Female
  • 18-35 years
  • Healthy
  • No herbal supplements/prescription medications (excl. contraceptive pill)
  • Non smoker
  • Native English speaker

Exclusion criteria

  • Consumes ≥ 1 portion oily fish/week
  • takes omega-3 supplement
  • Food allergies to treatment ingredients

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

159 participants in 3 patient groups, including a placebo group

DHA-rich fish oil
Active Comparator group
Description:
1 g DHA-rich fish oil containing 450 mg DHA + 90 mg EPA
Treatment:
Dietary Supplement: n-3 PUFAs
Dietary Supplement: n-3 PUFAs
EPA-rich fish oil
Active Comparator group
Description:
1 g EPA-rich fish oil containing 300 mg EPA + 200 mg DHA
Treatment:
Dietary Supplement: n-3 PUFAs
Dietary Supplement: n-3 PUFAs
Placebo
Placebo Comparator group
Description:
1 g Olive oil
Treatment:
Dietary Supplement: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems